Dr. Christopher Lee Stout, MD

Dr. Stout practices at Ozark Regional Vein Center in Rogers, Arkansas.

Dr. Stout's NPI, 1760697783, was assigned on May 12, 2007. Dr. Stout holds Arkansas license E-14776.

Dr. Stout's primary practice is Ozark Regional Vein Center, at 5433 W Walsh Ln, Rogers, AR 72758-8946. The practice phone is (479) 464-8346.

Dr. Stout's primary practice is Ozark Regional Vein Center in Rogers, Arkansas. Dr. Stout is also affiliated with Mercy Hospital Northwest Arkansas. The medical group on file is Ozark Regional Vein & Artery Center. Dmand AI also links Dr. Stout to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stout practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Stout's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Stout's licenses on file in 3 states: Arkansas, Georgia and Virginia.

CMS data shows 2,129 Medicare services from Dr. Stout across 28 procedure codes in 2024, for 445 Medicare patients. Medicare paid $742,106 for them. Every service was in an office.

CMS counts 445 Medicare patients who saw Dr. Stout in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stout's median patient age at 71, with 52% women.

In 2024, Dr. Stout wrote 226 Medicare Part D claims for 101 patients. 77% of them were for generic drugs. CMS names the drug for 182 of them, across 4 drugs with 11 or more claims each, at $25,979 in total drug cost. In 2023, CMS named 145 claims across 3 drugs.

Dr. Stout accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stout as offering telehealth. CMS counts 59 procedures of leg revascularization (restoring blood flow) by Dr. Stout, more than 96% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Stout, published from 2010 to 2021. 2021 was the busiest year, with 3. The most frequent topics are Endovascular Procedures, Stents and Angioplasty. Dr. Stout has published most often in J Endovasc Ther. Dr. Stout's most frequent co-authors are Jean Michel Panneton, MD, Sadaf Sadie Ahanchi, MD and Ehrin J. Armstrong, MD.

Dmand AI links Dr. Stout to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia. Open Payments lists research payments to Dr. Stout that name 1 trial.

CMS Open Payments shows 904 general payments to Dr. Stout from 51 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 32% of the total. AngioDynamics, Inc. paid the most, $93,182. It also lists 3 research payments totaling $14,406 in 2016, naming 1 clinical trial.